Related Experiment Video
Updated: Jul 1, 2025

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Autophagy sustains mitochondrial respiration and determines resistance to BRAFV600E inhibition in thyroid carcinoma
Sergio Díaz-Gago1, Javier Vicente-Gutiérrez1, Jose Manuel Ruiz-Rodríguez1
1Universidad de Alcalá, Facultad de Medicina y Ciencias de la Salud, Departamento de Biología de Sistemas, Unidad de Bioquímica y Biología Molecular, Madrid, Spain.
Abstract:
BRAFV600E is the most prevalent mutation in thyroid cancer and correlates with poor prognosis and therapy resistance. Although selective inhibitors of BRAFV600E have been developed, more advanced tumors such as anaplastic thyroid carcinomas show a poor response in clinical trials. Therefore, the study of alternative survival mechanisms is needed. Since metabolic changes have been related to malignant progression, in this work we explore metabolic dependencies of thyroid tumor cells to exploit them therapeutically. Our results show that respiration of thyroid carcinoma cells is highly dependent on fatty acid oxidation and, in turn, fatty acid mitochondrial availability is regulated through macroautophagy/autophagy. Furthermore, we show that both lysosomal inhibition and the knockout of the essential autophagy gene, ATG7, lead to enhanced lipolysis; although this effect is not essential for survival of thyroid carcinoma cells. We also demonstrate that following inhibition of either autophagy or fatty acid oxidation, thyroid tumor cells compensate oxidative phosphorylation deficiency with an increase in glycolysis. In contrast to lipolysis induction, upon autophagy inhibition, glycolytic boost in autophagy-deficient cells is essential for survival and, importantly, correlates with a higher sensitivity to the BRAFV600E selective inhibitor, vemurafenib. In agreement, downregulation of the glycolytic pathway results in enhanced mitochondrial respiration and vemurafenib resistance. Our work provides new insights into the role of autophagy in thyroid cancer metabolism and supports mitochondrial targeting in combination with vemurafenib to eliminate BRAFV600E-positive thyroid carcinoma cells.Abbreviations: AMP: adenosine monophosphate; ATC: anaplastic thyroid carcinoma; ATG: autophagy related; ATP: adenosine triphosphate; BRAF: B-Raf proto-oncogene, serine/threonine kinase; Cas9: CRISPR-associated protein; CREB: cAMP responsive element binding protein; CRISPR: clustered regularly interspaced short palindromic repeats; 2DG: 2-deoxyglucose; FA: fatty acid; FAO: fatty acid oxidation; FASN: fatty acid synthase; FCCP: trifluoromethoxy carbonyl cyanide phenylhydrazone; LAMP1: lysosomal associated membrane protein 1; LIPE/HSL: lipase E, hormone sensitive type; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; OCR: oxygen consumption rate; OXPHOS: oxidative phosphorylation; PRKA/PKA: protein kinase cAMP-activated; PTC: papillary thyroid carcinoma; SREBF1/SREBP1: sterol regulatory element binding transcription factor 1.
Insights
Thyroid cancer cells rely on fatty acid oxidation for survival, regulated by autophagy. Inhibiting autophagy forces cells to use glycolysis, increasing sensitivity to vemurafenib, a BRAF inhibitor.
Area of Science:
- Metabolic pathways in cancer
- Molecular mechanisms of thyroid cancer
- Autophagy and cancer therapeutics
Background:
- BRAFV600E mutation is common in thyroid cancer, linked to poor outcomes and resistance to targeted therapies.
- Advanced thyroid tumors like anaplastic thyroid carcinomas respond poorly to current BRAFV600E inhibitors.
- Understanding alternative survival mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the metabolic dependencies of thyroid tumor cells for potential therapeutic exploitation.
- To explore the role of autophagy in regulating fatty acid oxidation and cellular respiration.
- To assess the impact of modulating autophagy and glycolysis on sensitivity to BRAFV600E inhibitors.
Main Methods:
- Analysis of thyroid carcinoma cell respiration and its dependence on fatty acid oxidation (FAO).
- Investigation of macroautophagy/autophagy's role in regulating mitochondrial fatty acid availability.
- Assessment of cell survival and drug sensitivity following inhibition of autophagy, FAO, or glycolysis.
Main Results:
- Thyroid carcinoma cell respiration is highly dependent on FAO, with mitochondrial fatty acid availability regulated by autophagy.
- Inhibition of autophagy or lysosomal function enhances lipolysis, but this is not essential for cell survival.
- Thyroid tumor cells compensate for impaired oxidative phosphorylation by increasing glycolysis; this glycolytic boost is essential for survival in autophagy-deficient cells and enhances sensitivity to vemurafenib.
Conclusions:
- Autophagy plays a key role in thyroid cancer metabolism by regulating FAO.
- Targeting glycolysis in combination with BRAFV600E inhibition offers a promising therapeutic strategy.
- Mitochondrial targeting combined with vemurafenib may be effective for eliminating BRAFV600E-positive thyroid carcinoma cells.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondria

